Skip to main content

Table 3 Radiological response to treatment at 4–6 weeks after the concurrent chemoradiotherpay

From: A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence

Response

Overall

III

IVa

IVb

Recurrences

CR

21 (38.9)

8 (14.8)

3 (5.6)

3 (5.6)

7 (13.0)

PR

21 (38.9)

5 (9.3)

3 (5.6)

7 (13.0)

6 (11.1)

SD

7 (13.0)

1 (1.9)

0

3 (5.6)

3 (5.6)

PD

3 (5.6)

0

0

1 (1.9)

2 (3.7)

Missing

2 (3.7)

0

1 (1.9)

1 (1.9)

0

Total

54 (100.0)

14 (25.9)

7 (13.0)

15 (27.8)

18 (33.3)